Sonova AG
Sonova develops and provides hearing care solutions, including hearing aids and cochlear implants, to address hearing loss globally.
Founded in 1947, Sonova AG develops and provides innovative hearing care solutions aimed at restoring hearing and improving quality of life. The company operates in over 100 countries with a workforce of over 18,000 employees.
In the 2024/25 financial year, Sonova reported annual sales of CHF 3.9 billion and a net profit of CHF 547 million. Its technical domains encompass hearing aid technology, cochlear implants, wireless communication systems, and audiological care services.
The product portfolio includes hearing aids for various types of hearing loss and cochlear implants for severe to profound hearing loss. Sonova holds over 1,800 patents and design rights, reflecting its focus on innovation in healthcare and medical devices.